previous pauseresume next

مدیر مرکز

Name:ZaryNokhodian

 

Address:ResearchCenterfor Infectious Diseases and Tropical Medicine.‎

Isfahan University of Medical Sciences.‎ Isfahan Iran

 

Education:  Ph.D studen, Isfahan university

 

Professional experience:  Manager of Infectious Diseases and Tropical Medicine Research Center.‎

 

  

Research Projecs:

  

۱) Head project in:The Comparison of Quality of life between Patients with Chronic liver disease arising from hepatitis B and C and Control Group in 2004 - 2005.‎  

۲)  Head project in: The Assessment of the Relative frequency of prevalence of HBV, HCV, HIV in Street Children and teenager in Isfahan city in 2005-2006.‎  

۳) Head project in: The prevalence of hepatitis A, B and E Virus in Isfahan in 2005-2006.‎  

۴)  Head project in:The Assessment and Comparison of Risk Factors in B and C Hepatic patients referred to Infectious Diseases Research Center and Control Group refrred to Indocrean and Metabolism Research Center.‎  

۵) Head project in: The assessment of the Relative frequency of prevalence of HBV, HCV and HIV in incarcerated juvenile in Isfahan in 2006.‎  

۶) Head project in: The Assessment of the Relative frequency of prevalence of HAV in Street Children and teenager in Isfahan city.‎ 

۷) Head project in: Prevalence of HBV, HCV, HIV and syphilis among female prisoners in Isfahan, Iran.‎ 

۸) Head project in: Prevalence of HIV Infection in Cases with Previous History of Intravenous Drug Abuse by Community Based Announcement.‎

۹) Co operate in: Prevalence of infectious rate and identification of Brucella species in raw milk with Real time PCR system in Isfahan city.‎  

۱۰) Co operate in: Assessment of HIV & HCV co infection in IVDUs in Isfahan Province.‎

۱۱) Co operate in: Prevalence and Associated Risk factors of hepatitis B Infection in IVDU prison Inmates in Isfahan Province.‎

۱۲) Co operate in: The Seroepidemiology of HBV Infection and Associated Risk factors in DICs' IVDUs in Isfahan Province-2011.‎

۱۳) Co operate in: Prevalence of infectious rate and identification of Brucella species in dairy product with Real time PCR system in Isfahan city in 1389.‎  

۱۴) Co operate in: The Assessment and Comparision of HBS – Antibody Rate in Type 2 Diabetic and non-diabetic  Subjects after Hapatitis B Vaccination – 2003.‎  

۱۵) Co operate in: The assessment of the effects of zinc supplement on T- Lymphocyte profiles in patients with Aids refferd to Navab- safavi medical center -2005  

۱۶) Co operate in: The Assessment of Nutritional and Antropometric Status and thier relation ship with CD4+ Count in HIV+/AIDS patients in Isfahan Refferred to Navab Safavi Medical Center -2005.‎  

۱۷) Co operate in: The Comparision of seropvalence of Helicobacter Pylori in type 2 Diabetic and nondiabetic Subjects-2003.‎  

۱۸) Co operate in: The prevalence of Anti HAV (IgG) in patient with chronic Hepatitis B & C in tropical medicine research centers to compare with HAV in Isfahan.  

۱۹) Co operate in: Prevalence of hepatitis B and C virus infectious in boarbers in the Esfahan City-Iran 2007.‎   

۲۰) Co operate in: Study of establishing the research group of immunodeficiency diseases in in Infectious and Tropical Medicine Research Center and Alzahra University Hospital R & D Center.‎

۲۱) Co- operate in: Prevalence of HDV in chronic carriers of HBV in Isfahan in 2007.‎  

۲۲) Co- operate in: Prevalence of Hepatitis B and their Risk Factors in Transit Heavy Vehicle Drivers -2007.‎  

۲۳) Co- operate in: ''‎The assessment and management of hepatitis C in IVDA in Isfahan province'' 2008.‎  

۲۴) Co-operate in: ''‎The epidemiology of sexually transmitted infection and associated risk factors among women sex workers in Isfahan-Iran'' 2008.‎  

۲۵) Co- operate in: Prevalence and Genotyping of rotavirus in 2-60 month old children with acute diarrhea in ambulatory settings in Isfahan, Iran, 2010.‎  

۲۶) Co- operate in: The prevalence of Toxoplasmosis in Isfahan province.‎  

۲۷) Co- operate in: The   prevalence of  cytomegalovirus infection in people in  Isfahan province .‎  

۲۸) Co- operate in: A pilot study for Surveillance of acute respiratory infections among outpatients in Isfahan city (2009-2010)‎.‎  

۲۹) Co- operate in: Prevalence of hepatitis B, C, HIV infections and HBs antibody titer among private and governmental laboratories' staff in Esfahan city in 2009-2010.‎  

۳۰) Co- operate in: Comparison assessment of result biopsies of liver with Hepascore in patients genotypes 1.‎  

۳۱) Co- operate in: Evaluation of the frequency of genetic resistance to Lamivudine and Adefovir in treatment naïve patients with chronic hepatitis B infection: a pilot study.‎  

۳۲) Co- operate in: Prevalence of enteroviruses in CSF specimens from hospitalized patients diagnosed with meningitis/encephalitis with Real Time PCR in Isfahan city hospitals 2010-2011.‎ 

۳۳) Co- operate in: Etiologic assessment of pneumonia outbreak occurring in Isfahan Dastgerd prison by using  Real time PCR in 2010-2011.‎ 

۳۴) Co- operate in:  The Establishment of the first primary immunodeficiency Biobank in Isfahan University of Medical Sciences.‎  

۳۵) Co- operate in: Seroepidemiology and Risk Factors of HIV Infection in Prison's IVDUs in Isfahan Province.‎ 

۳۶) Co- operate in: The prevalence and Associated Risk factors of HIV Infection in Drop in Centers (DIC) in Isfahan Province.‎  

۳۷) Co- operate in: "Evaluation of fungal infection-candida and aspergillus species- in febrile hematological malignancies receiving chemotherapy by RT-PCR".‎ 

۳۸) Co project in: "Prevalence of infectious rate and identification of bacteria in febrile renal transplant recipients by RT-PCR".‎

۳۹) Co- operate in: ''‎Evaluation of fungal infection-candida and aspergillus species-in febrile renal transplant recipients by RT-PCR''‎.‎

 

 

Publication: Article

۱) Ataei B.‎ Khademi M.‎ Sadeghi A.‎ Nokhodian Z.‎ Kasaeian N.‎ Survey of hepatitis B risk factors in blood donors at Isfahan Province.‎ Blood 2005;‎ 2 :183-188.‎

۲) Shadzi M.‎ Karbassian A.‎ Khademi M.‎ Kasaian N.‎ Nokhodian Z.‎ Chabavizadeh J.‎ The prevalence of etiological agents of dermatophytoses in wrestlerrs of Isfahan.‎ Journal of Isfahan Medical school 2005;‎ 78: 77-80.‎ 

۳) Nokhodian Z, Ataei B.‎ The correlation between HBS-Ag and Alanine Aminotransferase level in chronic hepatitis B with PCR positive patients.‎  Iranian journal of infectious diseases and tropical medicine 2006;‎ 32: 29-33.‎ 

۴) Khademi MR, Amini M, Ataei B, Kasaeyan N, Nokhodian Z, Shoaei P.‎ Comparison of ABs-antibody Serum Leveles between Patients with Type 2 Diabetes Mellitus and Controls Following Vaccincation against Hepatitis B.‎ Journal of Isfahan Medical school 2007;‎ 84: 65-70.‎

۵) Ataei B, Nokhodian Z, JavadiAA,Kassaiean N, Shoaei P, Farajzadegan Z, Adibi P.Hepatitis E Virus in Isfahan province: a population based study.‎ Int J Infect Dis 2009;‎ 13: 67-71.‎ 

۶) Ataei B, Javadi AA, Nokhodian Z, Kassaian N, Shoaei P, Farajzadegan Z, Adibi P.HAV in Isfahan province: a popualtion-based study.‎ Tropical Gastroentology 2008;‎ 29 (3)‎: 160-162.‎ 

۷) Javadi A, Shafeai M, Ataei B, Nokhodian Z. Assessment of prevalence of the ambulances in Isfahan in 1384.‎ Homa-ye-salamat 2008;‎ 4: 24-28.‎  

۸) Nokhodian Z, Kassaian N, Ataei B, Javadi AA, Shoaei P, Farajzadegan Z, Adibi P.‎ Hepatitis B Markders in Isfahan, Central Iran: A Population-Based Study.‎ Hepatitis Monthly 2009;‎ 9(1)‎: 12-16.‎  

۹) Nokhodian Z, Ataei B, Adibi P, FarajZadegan Z, Rostami S.‎ Comparison of Quality of Life in Hepatitis B & Hepatitis C Patients.Journal of Isfahan Medical School 2009;‎ 598-604.‎  

۱۰) Khademi MR, Amini M, Ataei B, Nokhodian Z, Akbari M, Shoaei P, Kasaeian N, Noroozy A.‎ Is the Prevalence of Helicobacter Pylori Infection Different in TypeII Diabetes Mellitus Patients and Non-diabetic Individuals?Journal of Isfahan Medical school 2009;‎504-498.‎ 

۱۱) Ataei B, Ansari M, Yaran M, Nokhodian Z, Nejati H, Farajzadegan Z, Kasaeian N.‎ The Prevalence of Hepatitis B, Hepatitis C and their Risk Factors in Transit Heavy Vehicle Driversin Isfahan, Iran.‎ Journal of Isfahan Medical school 2009;‎:475-468.‎  

۱۲) Javadi AA,Ataei B, Shafei M, Nokhodian Z. Evaluation of satisfaction and its factors in patients in Emergency Departments of Isfahan province in 2005.‎ Journal of Homa-ye-salamat 2008;‎ 25: 17-21.‎  

۱۳)Nokhodian Z, Ataei B, Kassaian N, Adibi P, Farajzadegan Z.‎ Assemssment of quality of life in hepatitis B paients in Iran.‎ Indian J, Gastroentrol 2009;‎ 23 (3)‎: 115-119.‎  

۱۴) Tayeri K, Radfar SR, Yaran M, Kassaian N, Nokhodian Z, Ataei B, Fadaei R.‎ Isolation of Hepatitis C virus in Norgesic.‎ Hepatitis Monthly 2010;‎ 10 (1)‎: 65-66.‎ 

۱۵) Ataei B, Nokhodian Z, Babake A, Shoaei P, Mohammad Zadeh M, Sadeghi S.‎ Seroprevalence and associated Risk Factors of hepatitis B virus among street children in Isfahan, Iran.‎ Journal of Isfahan Medical School 2010;‎ 102: 788-797.‎   

۱۶) Ataei B, Nokhodian Z, Babake A, Shoaei P, Mohammad Zadeh M, Sadeghi S.‎ Seroprevalence of Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) infection among street children in Isfahan, Iran.‎ Tehran University Medical Journal 2010;‎ 11: 811-816.‎  

۱۷) Nokhodian Z, Ataei B, Yaran M, Shams A, Kassaian N, Kafashian AR, Ehsani M, Adibi P.‎ Hepatitis C in Correctional Centers: A Useful Experience.‎ Journal of Isfahan Medical School 2011;‎ 28‪(Special Issue on Hepatitis C)‬:1577-80.‎  

۱۸) Ataei B, Babak A, Yaran M, Kassaian N, Nokhodian Z, Meshkati M, Adibi P.‎ Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors.‎ Journal of Isfahan Medical School 2011;‎ 28‪(Special Issue on Hepatitis C)‬:974-8.‎  

۱۹) Fadaei Nobari R, Meshkati M, Ataei B, Heidari K, Kassaian N, Nokhodian Z, Shoaei P, Yaran M, Adibi P.‎ Positive hepatitis C virus antibody in Cases with History of Intravenous Drug Abuse via Community Announcement: A useful Experience.‎ Journal of Isfahan Medical School 2011;‎ 28 ‪(Special Issue on Hepatitis C)‬: 10-7.‎  

۲۰) Ataei B, Salehi M, Javadi AA, Khorvash F, Mortazavi A, Kasaian N, Nokhodian Z, Babak A.‎ The Frequency of High-risk Behaviors in Intravenous Drug Abusers Referred to Addiction Prohibition Centers in Isfahan, 2010.‎ Journal of Isfahan Medical School 2011;‎ 28(114)‎:837-42.‎  

۲۱) Kafashian AR, Nokhodian Z, Kassaian N, Babak A, Yaran M, Shoaei P, Ataei B, Adibi P.‎ The Experience of Hepatitis C Screening among Prison Inmates with Drug Injection History in 2008-2009.‎ Journal of Isfahan Medical School 2011;‎ 28‪(Special Issue on Hepatitis C)‬:29-35.‎  

۲۲) Meshkati M, Ataei B, Nokhodian Z, Yaran M, Babak A, Asgarianzadeh MR, Farshad M, Adibi P.‎ Hepatitis C Screening in Isfahan Drop in Centers: An Experience Description.‎ Journal of Isfahan Medical School 2011;‎ 28‪(Special Issue on Hepatitis C)‬:17-24.‎  

۲۳) Mobasherizadeh S, Kassaian N, Ataei B, Nokhodian Z, Adibi P.‎ Hepatitis C Screening in Intravenous Drug Users Under Treatment with Methadone: An Action Reserch Study.‎ Journal of Isfahan Medical School 2011;‎ 28‪(Special Issue on Hepatitis C)‬:36-40.‎  

۲۴) Ataei B, Meshkati M, Karimi A, Yaran M, Kassaian N, Nokhodian Z, Shoaei P, Adibi P.‎ Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan through Community Announcement: Pilot Study.‎ Journal of Isfahan Medical School 2011;‎ 28‪(Special Issue on Hepatitis C)‬:1581-6.‎ 

۲۵) Kassaian N, Nokhodian Z, Babak A, Ataei b, Adibi P.‎ Hepatitis C in Patients with Multi Blood Transfusion in Isfahan, Iran.‎ Journal of Isfahan Medical School 2011;‎ 28‪(Special Issue on Hepatitis C)‬:24-8.‎ 

۲۶) Ataei B, Javadi AA, Khorvash F, Fadaei R, Zakerzadeh Z, Nokhodian Z, Kassaian N.‎ Effect of Vitamin D Supplementation on the Treatment of PulmonaryTuberculosis with Positive Sputum Smear.‎ Journal of Isfahan Medical School 2011;‎ 28 (113)‎:781-6.‎ 30).‎ 

۲۷) Mostafavi SN, Ataei B, Nokhodian Z,Yaran M, BabakA.‎ Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study.‎ JRMS 2011;‎ 16 (4)‎: 496-501.‎ 

۲۸) Ataei B, Yazdani MR, Kalantari H, Yaran M, Nokhodian Z, Javadi AA, Babak A, Adibi P.‎ Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk fac­tors among chronic HBV infection cases.‎ Hepat Mon 2011;‎ 11(4)‎: 269-272.‎

۲۹) Etebari M, Khodarahmi GA, Jafarian-Dehkordi A, Nokhodian Z.Genotoxic effects of some l-[(benzofuran-2-yl)-phenylmethyl]-imidazoles on MCF-7 cell line.‎ RPS 2012;‎ 7 (3)‎:189-195.‎

۳۰) KassaianN,Adibi P,  Kafashaian AR, Yaran M, Nokhodian Z, Shoaei P, Hassannjead R,Babak A, Ataei B.‎ Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran.‎ IJPM 2012;‎
۳ (۳): S156-S161.‎

۳۱) Fadaei Nobari R, Meshkati M, Ataei B, Yazdani MR, Heidari K, Kassaian N, Nokhodian Z, Shoaei P, Yaran M, Adibi P.Identification of patients with hepatitis C virus infection in persons with background of intravenous drug use: the first community announcement-based study from Iran.‎ IJPM 2012;‎3(3)‎: S170-175.‎

۳۲) Shoaei P, Zeidabadinejad L, Hassannejad R, Ataei B, Yaran M, Kassaian N, Nokhodian Z, et al.Seroprevalence of hepatitis A in patients with chronic hepatitis C in Isfahan province.IJPM2012;‎ 3(3)‎: S102-S106.‎

۳۳) Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P.Prevalence and risk factors of anti HCV infection in patients with beta-thalassemia in Isfahan-Iran2012;‎ 3 (3)‎: S118-S123.‎

۳۴) Yazdani MR, Kassaian N, Ataei B, Nokhodian Z, Adibi P.Hepatitis C virus infection in patients with hemophilia in Isfahan,Iran.IJPM 2012;‎ 3 (3)‎: S89-S93.‎

۳۵) NokhodianZ,Meshkati M, Adibi P, Ataei B, KassaianN, Yaran M, Shoaei P, Hassannejad R.‎ Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors.‎ IJPM 2012;‎ 3(3)‎: S118-S123.‎

۳۶) NokhodianZ, AtaeiB, Kassaian N, Yaran M,Hassannejad R.‎ Seroprevalence and risk factors of Hepatitis C virus among juveniles in correctional center in Isfahan, Iran.‎ IJPM 2012;‎ 3(3)‎: S113-S117.‎    

۳۷) Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, Babak A, Ataie M.‎ Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran.‎ Hepatitis Monthly.‎ 2012;‎ In Press.‎   

۳۸)Nokhodian Z, Ataei B, Babak A, Yaran M, Pahlevani A.‎ Seroprevalence of Hepatitis A among Street Children, Isfahan, Iran.‎ Journal of Isfahan Medical School 2012;‎ 30(178)‎: 1-7.‎

۳۹) Ataei B, Khorvash F, Salehi M, Houshmand S, Kassaian N,  Babak A, Nokhodian Z, Ataei M.‎ The Relative Frequency of Depression and Anxiety in Patients with Hepatitis B Referring to Infectious Diseases and Tropical Medicine Research Center, Isfahan, Iran.‎ Journal of Isfahan Medical School 2012;‎ 29(169)‎: 1-7.‎

۴۰) Ataei M, Nokhodian Z, Ataei B, Kassaian N, Yaran M, Hassannejad R.‎ Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners.‎ Journal of Research in Medical Sciences 2013;‎ 18(1)‎: 71-73.‎

۴۱) Shoaei P, Zeidabadinejad L, Ataei B, Babak A,Nokhodian Z, Yaran M, Kassaian N.‎ Seroprevalence of Hepatitis A Virus in Patients with Chronic Hepatitis B or C in Isfahan Province, Iran.Journal of Isfahan Medical School.‎2012;‎ 30(199)‎.‎

۴۲) Ataei B, Zahraei SM, Pezeshki Z, Babak A, Nokhodian Z, Mobasherizadeh S, Hoseini SG. Baseline evaluation of hand hygiene compliance in three major hospitals, Isfahan, Iran.‎ J Hosp Infect.‎  ۲۰۱۳ ;۸۵(۱):۶۹-۷۲.

۴۳) Dibaj R, Ataei B, Yaran M , Nokhodian Z, Tayeri K, Zamanimoghadam A.‎ Prevalence of HIV infection in inmates with history of injection drug use and evaluation of risk factors, in Isfahan, Iran.‎ Pak J Med Sci 2013;‎29(1)‎Suppl:399-402.‎

۴۴) Hashemipour M, Nokhodian Z, Yaran M, Ataei B, Tayeri K, Nobari RF, et al.‎ Prevalence of HIV infection in individuals with history of intravenous drug use via community announcement in Isfahan- Iran.‎ Pak J Med Sci 2013;‎ 29(1)‎Suppl:395-398.‎

۴۵) Javadi AA, Ataei B, Yaran M, Nokhodian Z, Kassaian N, Tayeri K, et al.‎ Prevalence of HIV infection and related risk factors in Isfahan Drop in Centers.‎ Pak J Med Sci 2013;‎ 29(1)‎Suppl:346-350.‎

 

۴۶)Nokhodian Z, Yaran M, Adibi P, Kassaian N, Meshkati M, Ataei B.‎ Seroprevalence of hepatitis B markers among incarcerate intravenous drug users.‎ J Res Med Sci 2014;‎19:S13-S16.‎

۴۷Javadi A, Ataei B, Kassaian N, Nokhodian Z, Yaran M.‎ Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in the drop in centers.‎ J Res Med Sci 2014;‎19:S17-S21.‎

 

۴۸-Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, Mirmoghtadaee P, Hovsepian S, Mostafavi S-N.Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran.‎ J Res Med Sci 2014;‎19:S56-S63

۴۹- Khodadoostan M, Ataei B, Shavakhi A, Tavakoli T, Nokhodian Z, Yaran M.‎ The assessment of hepatitis B seroprevalence in persons with intravenous drug use history in the Isfahan province: Community-based study.‎ J Res Med Sci 2014;‎19:65-8.‎

۵۰-Baseline evaluation of hand hygiene compliance in three major hospitals, Isfahan, Iran

                ۵۱-Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers

  Seroprevalence of hepatitis B markers among incarcerated intravenous drug users

Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran

The assessment of hepatitis B seroprevalence in persons with intravenous drug use history in the Isfahan province: Community-based study

Surveillance of acute respiratory infections among outpatients: A pilot study in Isfahan city

Prevalence of Co-Infections of Hepatitis B and C Among Drug Abuse: Prisoners and Its Association With High Risk Behavior

The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons

 

 

Dermatophytes contamination of wrestling mats in sport centers of Isfahan, Iran

 

Seroprevalence of Cytomegalovirus infection and estimate of congenital Cytomegalovirus infection in Isfahan state, Iran: A population based study

prevalence of HIV infection in inmates with history of injection drug use and evaluation of risk factors, in Isfahan, Iran

Prevalence of HIV infection and related risk factors in Isfahan Drop in Centers

Prevalence of HIV infection in individuals with history of intravenous drug use via community announcement in Isfahan-Iran

Mustard gas exposure in Iran-Iraq war - A scientometric study

 

 

 

۱) Author of book: “Hepatitis in Simple language”, 2003, IUMS.‎ 

۲) Author of book (Translation): “National Health Research Sistem”, 2002, IUMS.‎ 

 

 

Conference Presentations:

۱) The 14 th Iranian congress on infectious disease and tropical medicine.‎ 17-21 Dec .‎2005.‎ 

۲) ۱۶ th European congress of clinical microbiology and infectious diseases.‎ Nice/France, April1-4,2006.‎ 

۳) The 1St national congress of Endocrine & metabolism updates .‎31 Oct &1 Nov 2007 

۴) The first congress on risk factors, 2006, Zahedan, Iran 

۵) Correlation between HBe Ag and Alanine Aminotransferase Levels in Hepatitis B with PCR Positive Patients.‎ 12th International Congress on Infectious Diseases, Lisbon Prtugal, June 15-18, 2006.‎ 

۶) Assessment of Quality of  Life in Hepatitis C Patients in Isfahan, Iran.‎12th International Congress on Infectious Diseases, Lisbon Prtugal, June 15-18, 2006.‎ 

۷)  The 1st National Congress of Psychosomatic Medicine.‎ 

۸) HEV in Isfahan Province: A popualtion based study.‎ 6th Iranian Congress Gastroenterology in 2006.‎ 

۹) HBV Markers in Isfahan Province 2006.‎6th Iranian Congress Gastroenterology in 2006.‎ 

۱۰) Correlation Between HBe Ag and Alanine Aminotransferase levels in chronic Hepatitis B with PCR positive patients.‎ 12th International Congress on Infectious Diseases, Lisbon, Portugal.‎ June 15-18, 2008.‎  

۱۱) Assessment Quality of life in Hepatitis C patients in Isfahan Iran.‎ International Congress on Infectious Diseases, Lisbon, Portugal.‎ June 15-18, 2008.‎  

۱۲) HBV Markers in Central of Iran, 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia,June 19-22, 2008.‎  

۱۳) Knowledge and practice about Aids.‎ Hepatitis B and C in Barbers.‎ 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia,June 19-22, 2008.‎  

۱۴) Seroepidemilogy of HEV Infection in Isfahan, Iran.‎ A Community-Based study, 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia, June 19-22, 2008.‎  

۱۵) Pleural Fluid Cholestrol and Bilirubin value in Diagnostic of Exudative from Transudative pleural Effeusion, 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia,June 19-22, 2008.‎  

۱۶) Assessment of Quality of life in Hepatitis B patients.‎ 13th International Congress on Infectious Diseases, KualaLumpur, Malaysia,June 19-22, 2008.‎  

۱۷) Comparison of HBs-Ab serum levels between patients with Type 2 Diabetes Mellitus and Controls Following vaccination against Hepatitis B.‎ The 1st National Congress of Endocrine & Metabolism updates, 2007, Isfahan, IRAN.‎ 

۱۸) Delta hepatitis infection in patients with chronic hepatitis B infection in Isfahan, Iran.‎ 19th European Congress Microbiology and Infectious Diseases, Helsinki, Finland 16-19 may 2009.‎  

۱۹) Anti-HCV positivity in Cases with History of Intravenous Drug Abuse via Community Annoucenent: A useful Experience.‎ Iranian Association of Gastroentrology and Hepatology, Tehran  2009.‎ 

Abstracts in Journals:

۱) Shadzi S, Krbassian A, Kassaian N, Khademi M, Nokhodian Z. The prevalence of aetiologic agents of dermatophytosis in wrestles in Isfahan, Iran.‎ 16th Euaopean Congress of Clinical Microbiology and Infectious Diseases.‎ Nice/‎ France.‎ April 1-4 2006.‎ Journal of Clinical Microbiology and Infection.‎  

۲)  Ataei B, Nokhodian Z, Javadi AA,Shoaei P, Kassaian N , Farajzadegan Z, Adibi P.‎ HBV markers in central of Iran.‎ 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.‎  

۳)  Ataei B, Araghi A, Kassaian N, Nokhodain Z, Karimi I. Pleural Fuild cholesterol and bilirubin value in diagnostic of exudative from transudative pleural effusion.‎ 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.‎  

۴) Ataei B, Saidi A, Kassaian N, Nokhodian Z, Jalali M.‎ Knowledge and practice about AIDS, hepatitis B and C in barbers.‎ 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.‎  

۵) Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, Adibi P.‎ Seroepidemiology of hepaitits E virus infection in Isfahan-Iran: a community-based study.‎ 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.‎  

۶) Khademi M, Amini M Ataei B, Kassaian N, Nokhodian Z, Shoaei P.‎ The comparison of HBs-Ab serum levels between patients with type 2 diabetes mellitus and healthy non-diabetic ones following vaccination.‎ International Scientific Exchange.‎ 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.‎  

۷) Kassaian N, Pourahmad M, Nokhodian Z, Amini M, Ataei B.‎ Risk factors for hepatitis B in Isfahan, Iran.‎ 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.‎  

۸)  Nokhodian Z, Ataei B, Kassaian N, Adibi P.‎ Assessment of quality of life in hepaitis B patients.‎ 13th ICID, Kuala Lumpur, Malaysia-June 19-22, 2008.‎ 

۹) Ataei B, Kalantari H.‎ Soleimani S, Javadi A, Adibi P, Yaran M, Nokhodian Z. Delta hepatitis infection in patients with chronic hepatitis B infection in Isfahan, Iran.‎ 19th European Congress Microbiology and Infectious Diseases, Helsinki, Finland 16-19 may 2009.‎  

۱۰) Ataei B, Nokhodian Z, Babak A, Shoaei P, Mohammadzadeh S, Sadeghi M, Ataei M.‎ Seroprevalence of Hepatitis C (HCV) infection among street children in Isfahan, Iran.The 21st Conference of the Asian Pacific Association for the Study of the Liver.‎ Thailand, 17-22 February 2011.‎ Hepatol Int (2011)‎;‎ 5: 3-558.‎ 

۱۱) Ataei B, Nokhodian Z, Kassaian N, Babak A, Shoaei P, Meshkati M, Ataei M, Adibi P.‎ Hepatitis C in IVDUs  in Isfahan, Iran, 2008.‎ The 21st Conference of the Asian Pacific Association for the Study of the Liver.‎ Thailand, 17-22  February 2011.‎ Hepatol Int (2011)‎;‎ 5: 3-558.‎ 

۱۲) Ataei B, Shoaei P, Nokhodian Z, Babak A, Yaran M, Kassaian N, Ataei M, Foroughifar M.‎ Prevalence of hepatitis B and C Virus in barbers, Isfahan (Iran), 2007.‎ The 21st Conference of the Asian Pacific Association for the Study of the Liver.‎ Thailand, 17-22  February 2011.‎  Hepatol Int (2011)‎;‎ 5: 3-558.‎  

۱۳) Fadaei Nobari R, Adibi P, Ataei B, Kassaian N, Meshkati M, Babak A, Nokhodian Z, Yaran M.‎ Anti-HCV Positivity in Cases with History of Intravenous Drug  Abuse via Community Announcement: A useful Experience.‎ The 21stConference of the Asian Pacific Association for the Study of the Liver.‎ Thailand, 17-22  February 2011.‎ Hepatol Int (2011)‎;‎ 5: 3-558.‎